ACC's 58th Annual Scientific Sessions is March 29-31
March 2, 2009 - The American College of Cardiology's 58th Annual Scientific Session is set for March 29 – 31, in Orlando, FL.
The ACC's Innovation in Intervention: i2 Summit 2009 is being held in partnership with Cardiovascular Research Foundation. ACC.09 and i2.09 will feature the latest and most innovative findings in cardiovascular science, as well as the most clinically relevant practical applications. The meeting is an opportunity to hear the latest innovative information in the world of clinical cardiology. The event offers busy cardiovascular professionals the chance to participate in two meetings that now offer synchronized timing, making it easier to move from session to session within each meeting and between each meeting.
Cardiovascular professionals can interact with experts from around the world and discuss diverse approaches to similar clinical problems. Oral presentations and state-of-the-art lectures will encourage a tradition of lifelong learning for cardiovascular teams who desire to increase their knowledge on all areas of cardiology and intervention. The latest breakthroughs in science will also be presented in the Late-Breaking Clinical Trial and live case sessions.
The event includes an expo of about 360 medical device manufacturers, drug companies and professional societies.
For more information: http://acc09.acc.org
More like this
- Phase II Results from Trial of Relaxin for Heart Failure to be Presented at ACC
- Several Societies Host Programs During ACC 2009
- Phase 3 Data from Genetically Targeted Beta Blocker for Chronic Heart Failure Presented at ACC
- ACC, CRF Launch Five-Year Partnership for ACC’s i2 Summit
- PLC to Release RenalGuard Safety Data at ACC